Personalized 3D kidney model produced by rapid prototyping method and its usefulness in clinical applications

Por Lee, Hakmin, Nguyen, Ngoc Ha, Hwang, Sung Il, Lee, Hak Jong, Hong, Sung Kyu, Byun, Seok-Soo
Publicado no Int Braz J Urol (2018)

Downregulation of Noxa by RAF/MEK inhibition counteracts cell death response in mutant B-RAF melanoma cells

Por Basile, Kevin J, Aplin, Andrew E
Publicado em 2012

Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL

Por Slager, Susan L., Rabe, Kari G., Achenbach, Sara J., Vachon, Celine M., Goldin, Lynn R., Strom, Sara S., Lanasa, Mark C., Spector, Logan G., Rassenti, Laura Z., Leis, Jose F., Camp, Nicola J., Glenn, Martha, Kay, Neil E., Cunningham, Julie M., Hanson, Curtis A., Marti, Gerald E., Weinberg, J. Brice, Morrison, Vicki A., Link, Brian K., Call, Timothy G., Caporaso, Neil E., Cerhan, James R.
Publicado em 2011

Diagnosis Of The Chronic Lymphocytic Leukemia (CLL) Using A Raman-Based Scanner Optimized For Blood Smear Analysis (M3s Project)

Por M. Fere, L.H. Liu, C. Gobinet, A. Beljebbar, V. Untereiner, J.-F. Angiboust, M. Manfait, G. Gheldof, H. Jacquemin, S. Walbrecq, E. Cornet, X. Troussard, B. Chatelain, J. Angelo, M. Chollat, J. Klossa, O. Piot
Publicado em 2016-06-01

Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice

Por Raveche, Elizabeth S., Salerno, Erica, Scaglione, Brian J., Manohar, Vijaya, Abbasi, Fatima, Lin, Yi-Chu, Fredrickson, Torgny, Landgraf, Pablo, Ramachandra, Sumant, Huppi, Konrad, Toro, Jorge R., Zenger, Vincent E., Metcalf, Robert A., Marti, Gerald E.
Publicado em 2007

Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. I. A hybridoma...

Por Brooks, D A, Beckman, I, Bradley, J, McNamara, P J, Thomas, M E, Zola, H
Publicado em 1980

Myelin protein P(0)-specific IgM producing monoclonal B cell lines were established from...

Por KVARNSTRÖM, M, SIDOROVA, E, NILSSON, J, EKERFELT, C, VRETHEM, M, SÖDERBERG, O, JOHANSSON, M, ROSÉN, A, ERNERUDH, J
Publicado em 2002

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study

Por Rawstron, A C, Fazi, C, Agathangelidis, A, Villamor, N, Letestu, R, Nomdedeu, J, Palacio, C, Stehlikova, O, Kreuzer, K-A, Liptrot, S, O'Brien, D, de Tute, R M, Marinov, I, Hauwel, M, Spacek, M, Dobber, J, Kater, A P, Gambell, P, Soosapilla, A, Lozanski, G, Brachtl, G, Lin, K, Boysen, J, Hanson, C, Jorgensen, J L, Stetler-Stevenson, M, Yuan, C, Broome, H E, Rassenti, L, Craig, F, Delgado, J, Moreno, C, Bosch, F, Egle, A, Doubek, M, Pospisilova, S, Mulligan, S, Westerman, D, Sanders, C M, Emerson, R, Robins, H S, Kirsch, I, Shanafelt, T, Pettitt, A, Kipps, T J, Wierda, W G, Cymbalista, F, Hallek, M, Hillmen, P, Montserrat, E, Ghia, P
Publicado no Leukemia (2016)

A novel antibody–drug conjugate targeting SAIL for the treatment of hematologic malignancies

Por Kim, S Y, Theunissen, J-W, Balibalos, J, Liao-Chan, S, Babcock, M C, Wong, T, Cairns, B, Gonzalez, D, van der Horst, E H, Perez, M, Levashova, Z, Chinn, L, D‘Alessio, J A, Flory, M, Bermudez, A, Jackson, D Y, Ha, E, Monteon, J, Bruhns, M F, Chen, G, Migone, T-S
Publicado no Blood Cancer J (2015)

PEITC-mediated inhibition of mRNA translation is associated with both inhibition of mTORC1 and increased eIF2α phosphorylation in established cell lines and primary human leukemia cells

Por Yeomans, Alison, Lemm, Elizabeth, Wilmore, Sarah, Cavell, Breeze E., Valle-Argos, Beatriz, Krysov, Sergey, Hidalgo, Marina Sanchez, Leonard, Elodie, Willis, Anne E., Forconi, Francesco, Stevenson, Freda K., Steele, Andrew J., Coldwell, Mark J., Packham, Graham
Publicado no Oncotarget (2016)

Viability and stress protection of chronic lymphoid leukemia cells involves overactivation of mitochondrial phosphoSTAT3Ser(727)

Por Capron, C, Jondeau, K, Casetti, L, Jalbert, V, Costa, C, Verhoyen, E, Massé, J M, Coppo, P, Béné, M C, Bourdoncle, P, Cramer-Bordé, E, Dusanter-Fourt, I
Publicado no Cell Death Dis (2014)

Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia

Por Malcikova, J, Stano-Kozubik, K, Tichy, B, Kantorova, B, Pavlova, S, Tom, N, Radova, L, Smardova, J, Pardy, F, Doubek, M, Brychtova, Y, Mraz, M, Plevova, K, Diviskova, E, Oltova, A, Mayer, J, Pospisilova, S, Trbusek, M
Publicado no Leukemia (2015)

Antifungal Diterpene Alkaloids from the Caribbean Sponge Agelas citrina: Unified Configurational Assignments of Agelasidines and Agelasines

Por Stout, E. Paige, Yu, Lily C., Molinski, Tadeusz F.
Publicado em 2012

ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol

Por Mahoney, Emilia, Lucas, David M., Gupta, Sneha V., Wagner, Amy J., Herman, Sarah E. M., Smith, Lisa L., Yeh, Yuh-Ying, Andritsos, Leslie, Jones, Jeffrey A., Flynn, Joseph M., Blum, Kristie A., Zhang, Xiaoli, Lehman, Amy, Kong, Hui, Gurcan, Metin, Grever, Michael R., Johnson, Amy J., Byrd, John C.
Publicado em 2012

Potent Fluorinated Agelastatin Analogues for Chronic Lymphocytic Leukemia: Design, Synthesis, and Pharmacokinetic Studies

Por Stout, E. Paige, Choi, Michael Y., Castro, Januario E., Molinski, Tadeusz F.
Publicado em 2014

MBL or CLL: Which Classification Best Categorizes the Clinical Course of Patients with an Absolute...

Por Shanafelt, Tait D., Kay, Neil E., Call, Tim G., Zent, Clive S., Jelinek, Diane F., LaPlant, Betsy, Morice, William G., Hanson, Curtis A.
Publicado em 2008

Torque Teno Virus 10 Isolated by Genome Amplification Techniques from a Patient with Concomitant Chronic Lymphocytic Leukemia and Polycythemia Vera

Por Chu, Charles C, Zhang, Lu, Dhayalan, Arjun, Agagnina, Briana M, Magli, Amanda R, Fraher, Gia, Didier, Sebastien, Johnson, Linda P, Kennedy, William J, Damle, Rajendra N, Yan, Xiao-Jie, Patten, Piers E M, Teichberg, Saul, Koduru, Prasad, Kolitz, Jonathan E, Allen, Steven L, Rai, Kanti R, Chiorazzi, Nicholas
Publicado em 2011

Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival sig...

Por Herman, Sarah E. M., Gordon, Amber L., Wagner, Amy J., Heerema, Nyla A., Zhao, Weiqiang, Flynn, Joseph M., Jones, Jeffrey, Andritsos, Leslie, Puri, Kamal D., Lannutti, Brian J., Giese, Neill A., Zhang, Xiaoli, Wei, Lai, Byrd, John C., Johnson, Amy J.
Publicado em 2010

A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia

Por Sellick, Gabrielle S., Goldin, Lynn R., Wild, Ruth W., Slager, Susan L., Ressenti, Laura, Strom, Sara S., Dyer, Martin J. S., Mauro, Francesca R., Marti, Gerald E., Fuller, Stephen, Lyttelton, Matthew, Kipps, Thomas J., Keating, Michael J., Call, Timothy G., Catovsky, Daniel, Caporaso, Neil, Houlston, Richard S.
Publicado em 2007

Pre-clinical modeling of novel therapeutics in chronic lymphocytic leukemia: the tools of the trade

Por Herman, Sarah E. M., Wiestner, Adrian
Publicado no Semin Oncol (2016)